ViiV Healthcare to present data from largest head─to─head randomised trial for 2─drug regimen Dovato against 3─drug ...
GSK plc announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, will be presenting the largest head-to-head, randomised clinical trial (RCT) of the 2-drug regimen Dovato ( …